Know more

Context and issues

Within the framework of the H2020 project ROADMAP (Rethinking Of Antimicrobial Decision systems in the Management of Animal Production) coordinated by INRAE (https://www.roadmap-h2020.eu), twelve Living Labs aiming at co-constructing strategies for a more prudent use of antibiotics have been set up. In France, one of these participatory schemes concerns pig and poultry farms, where the use of antibiotics has been greatly reduced but where it is no longer appropriate to consider only the quantitative aspect. Indeed, in these sectors, "antibiotic-free" labels or charters have emerged which may constitute an attack on the health and well-being of animals by preventing the therapeutic use of antibiotics on sick animals. This Living Lab brings together the Ministry of Agriculture (DGAl), veterinary authorities (order, trade union, technical organisations) and the interprofessions and technical institutes of the pig and poultry sectors. The ImpresS ex ante method developed by CIRAD is used to facilitate the participatory process.

Results

The stages of the ImpresS ex ante process are carried out through meetings (two already organised, two to come in the first quarter of 2022) with the aim of identifying collective strategies to be implemented. A sytemic analysis of the intervention context has been conducted and a shared and desirable vision of the future for the prudent use of anitibiotics has been formulated (this includes a set of common intentions and a variety of desirable impacts). The field of action of the collective's intervention (i.e. over which it has legitimacy) was defined to serve as a basis for the construction of the strategies necessary for the success of the intervention. The strategies will be selected by the stakeholders because they are likely to enable progress to be made towards a virtuous use of antibiotics (towards "better" rather than just "less") that will guarantee the health and well-being of the animals, the sustainability of these sectors and of the veterinary network in the region.

Perspectives

An extension of the group to other stakeholders (distributors, consumers) is envisaged to validate the selected strategies. The implementation of these strategies will lead to specific research projects.

Valorisation

In addition to scientific publications and other communication media on the results of this participatory process, this work will contribute to version 3 of the Ecoantibio plan, the construction of which will begin in 2022 at the same time as the revision of the interministerial roadmap One Health. Similarly, this work will feed into the reflection on the means implemented to respond to the European regulation that requires the reporting of data on the sale and use of antibiotics.